A first-of-its-kind implant has just been granted approval from the US Food and Drug Administration (FDA) for the treatment ...

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...

The US Food and Drug Administration has approved a pill-sized device for treating rheumatoid arthritis, marking the first ...

Rheumatoid arthritis (RA) is a chronic autoimmune disease in which the immune system mistakenly attacks the lining of the ...

The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid ...

US FDA approves SetPoint Medical’s novel neuroimmune modulation device, SetPoint System for rheumatoid arthritis: Valencia, California Saturday, August 2, 2025, 17:00 Hrs [IST] ...

The SetPoint System consists of a neurostimulation device that is surgically placed under general anesthesia on the vagus nerve.

Medical professionals observe that GLP-1 medications like Ozempic show promise for treating rheumatoid arthritis alongside other inflammatory conditions.

SetPoint Medical announced today that the FDA approved its SetPoint neuroimmune modulation system for treating rheumatoid ...

SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...

Rheumatoid arthritis (RA) impacts thousands of Australians each year, causing pain, stiffness, and a steady decline in ...